Covid-19: Pfizer vaccine’s efficacy declined from 96% to 84% four months after second dose, company reports

The Pfizer-BioNTech vaccine’s efficacy against SARS-CoV-2 peaked at 96.2% at seven days to two months after the second dose and then declined to 83.7% at four months, a preprint from Pfizer has…


Read Original Article: Covid-19: Pfizer vaccine’s efficacy declined from 96% to 84% four months after second dose, company reports »